Cerebral Amyloid-β Deposition, Axial Features, and Cognitive Alterations in Patients with Parkinson’s Disease Treated with Bilateral STN-DBS: A Long-Term Cohort Study
Authors:
- Francesco CavallieriFrancesco Cavallieri
- Alessandro FraternaliAFAlessandro Fraternali
- Annachiara ArnoneAAAnnachiara Arnone
- Isabella CampaniniICIsabella Campanini
- Alessandro MartiAMAlessandro Marti
- Annalisa GessaniAGAnnalisa Gessani
- Valentina FioravantiVFValentina Fioravanti
- Maria Angela MolinariMMMaria Angela Molinari
- Giulia Di RausoGRGiulia Di Rauso
- Francesca AntonelliFAFrancesca Antonelli
- Vittorio RispoliVRVittorio Rispoli
- Alberto FelettiAFAlberto Feletti
Open Access
- 10 December 2024
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (12) , 1150
Abstract
Objectives: Our aim was to evaluate the possible long-term cerebral deposition of amyloid-β in patients with PD treated with subthalamic nucleus deep brain stimulation (STN-DBS) and its possible influence on axial and cognitive variables. Methods: Consecutive PD patients treated with bilateral STN-DBS with a long-term follow-up were included. The amyloid-β deposition was evaluated postoperatively through an 18F-flutemetamol positron emission tomography (PET) study. Axial symptoms were assessed using a standardized clinical–instrumental approach. The speech was assessed by perceptual and acoustic analysis, while gait was assessed by means of the instrumented Timed Up and Go test (iTUG). Motor severity was evaluated by applying the UPDRS part III score and subscores, while cognitive functions were assessed through a complete neuropsychological assessment. Different stimulation and drug conditions were assessed: on-stimulation/off-medication, off-stimulation/off-medication, and on-stimulation/on-medication conditions (single- and dual-task). Results: In total, 19 PD patients (male: 11; age: 63.52 years; on-stimulation/on-medication UPDRS-III: 17.05) with a five-year postoperative follow-up were included. The amyloid-β deposition was found in 21% of patients (4/19) with a prevalent involvement of prefrontal, limbic, and parietal areas. Compared with patients without amyloid-β deposition, PD patients with positive 18F-flutemetamol in the PET study showed a higher preoperative UPDRS-I (p = 0.037) score. Conclusions: Our results suggest that in the long term, after STN-DBS, a significant percentage of PD patients may present brain amyloid-β deposition. However, larger samples are needed to evaluate the possible role of amyloid-β deposition in the development of axial and cognitive alterations after surgery.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based SettingJAMA Neurology, 2018
- Clinical markers for identifying cholinergic deficits in Parkinson's diseaseMovement Disorders, 2014
- Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography studyMovement Disorders, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson DiseaseJAMA Neurology, 2013
- How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scaleMovement Disorders, 2013
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementiaMovement Disorders, 2012
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesMovement Disorders, 2012
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMovement Disorders, 2007